Cell Cycle Proteins and Retinal Degeneration: Evidences of New Potential Therapeutic Targets

被引:5
|
作者
Arsenijevic, Yvan [1 ]
机构
[1] Univ Lausanne, Dept Ophthalmol, Unit Gene Therapy & Stem Cell Biol, 15 Av France, CH-1004 Lausanne, Switzerland
来源
RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY | 2016年 / 854卷
关键词
Retinal degeneration; Alzheimer's disease; Parkinson's disease; CDK5; BMI1; Cell cycle; Neuroprotection; Stroke; CDK4; DEPENDENT KINASES; DEATH; NEURODEGENERATION; TOXICITY; NEURONS; PATHWAY;
D O I
10.1007/978-3-319-17121-0_49
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
During different forms of neurodegenerative diseases, including the retinal degeneration, several cell cycle proteins are expressed in the dying neurons from Drosophila to human revealing that these proteins are a hallmark of neuronal degeneration. This is true for animal models of Alzheimer's, and Parkinson's diseases, Amyotrophic Lateral Sclerosis and for Retinitis Pigmentosa as well as for acute injuries such as stroke and light damage. Longitudinal investigation and loss-of-function studies attest that cell cycle proteins participate to the process of cell death although with different impacts, depending on the disease. In the retina, inhibition of cell cycle protein action can result to massive protection. Nonetheless, the dissection of the molecular mechanisms of neuronal cell death is necessary to develop adapted therapeutic tools to efficiently protect photoreceptors as well as other neuron types.
引用
收藏
页码:371 / 377
页数:7
相关论文
共 50 条
  • [1] Histone Deacetylase: Therapeutic Targets in Retinal Degeneration
    Daly, Conor
    Yin, Jun
    Kennedy, Breandan N.
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 : 455 - 461
  • [2] Retinal degeneration depends on Bmi1 function and reactivation of cell cycle proteins
    Zencak, Dusan
    Schouwey, Karine
    Chen, Danian
    Ekstrom, Per
    Tanger, Ellen
    Bremner, Rod
    van Lohuizen, Maarten
    Arsenijevic, Yvan
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (07) : E593 - E601
  • [3] Therapeutic potential of BAK gene silencing in aluminum induced neural cell degeneration
    Zhang, Q. L.
    Niu, Q.
    Shi, Y. T.
    Niu, P. Y.
    Liu, C. Y.
    Zhang, L.
    Zhang, C.
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2009, 103 (11) : 1514 - 1520
  • [4] Cell Cycle Kinases in Osteosarcoma: Potential for Therapeutic Intervention
    Cheng, Li
    Wang, Chongchong
    Jing, Juehua
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (31) : 4830 - 4834
  • [5] Unveiling the therapeutic potential and mechanisms of stanniocalcin-1 in retinal degeneration
    Wang, Kexin
    Liu, Yashuang
    Li, Siyu
    Zhao, Na
    Qin, Fangyuan
    Tao, Ye
    Song, Zongming
    SURVEY OF OPHTHALMOLOGY, 2025, 70 (01) : 106 - 120
  • [6] Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma
    Mamede, A. C.
    Guerra, S.
    Laranjo, M.
    Santos, K.
    Carvalho, M. J.
    Carvalheiro, T.
    Moura, P.
    Paiva, A.
    Abrantes, A. M.
    Maia, C. J.
    Botelho, M. F.
    PATHOLOGY & ONCOLOGY RESEARCH, 2016, 22 (04) : 689 - 697
  • [7] Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease
    Araki, Takako
    Liu, Ning-Ai
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [8] Future perspective of stem cell-derived exosomes: Cell-free therapeutic strategies for retinal degeneration
    Liu, Zibin
    Zeng, Fang
    Zhang, Yao
    Liu, Yongqing
    Li, Zhuo
    Liu, Xiao
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [9] Cell cycle machinery in oncology: A comprehensive review of therapeutic targets
    Cavalu, Simona
    Abdelhamid, Amir Mohamed
    Saber, Sameh
    Elmorsy, Elsayed A.
    Hamad, Rabab S.
    Abdel-Reheim, Mustafa Ahmed
    Yahya, Galal
    Salama, Mohamed M.
    FASEB JOURNAL, 2024, 38 (11)
  • [10] Exosomes: Potential Disease Biomarkers and New Therapeutic Targets
    Mosquera-Heredia, Maria, I
    Morales, Luis C.
    Vidal, Oscar M.
    Barcelo, Ernesto
    Silvera-Redondo, Carlos
    Velez, Jorge, I
    Garavito-Galofre, Pilar
    BIOMEDICINES, 2021, 9 (08)